Picture of The Chemours logo

CC — The Chemours News Story

0.000.00%
us flag iconLast trade - 00:00
Basic MaterialsAdventurousMid CapContrarian

Chemours Co reports results for the quarter ended in September 30 - Earnings Summary

* Chemours Co  CC.N  reported quarterly adjusted earnings of
40
cents​​ per share for the quarter ended September 30, lower than
the same quarter last year, when the company reported EPS of 63
cents.  The mean expectation of ten analysts for the quarter was
for earnings of 28 cents per share. Wall Street expected
results to range from 23 cents to 34 cents per share.
    * Revenue rose 0.9% to $1.50 billion from a year ago;
analysts
expected $1.44 billion. 
    * Chemours Co's reported EPS for the quarter was a loss
of 18
cents​.
    * The company reported a quarterly loss of $27 million.
    * Chemours Co shares had fallen by 12.3% this quarter and
lost 43.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 37.5%
in the last three months.​ 
    * In the last 30 days, four analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 6
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the diversified
chemicals peer group is also "hold"

Wall Street's median 12-month price target for Chemours Co is
26.00 
This summary was machine generated from LSEG data November 4 at
03:28 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.28           0.40           Beat
 Jun. 30 2024      0.57           0.38           Missed
 Mar. 31 2024      0.18           0.32           Beat
 Dec. 31 2023      0.25           0.31           Beat

Recent news on The Chemours

See all news